First Steps Toward a Whole-Body Map of Molecular Responses to Exercise
Pacific Northwest National LaboratoryPNNL contributes to a nationwide research consortium investigating the molecular mechanisms triggered by endurance training.
PNNL contributes to a nationwide research consortium investigating the molecular mechanisms triggered by endurance training.
A new UC Davis study finds biomarkers that could identify patients with 22q11.2 deletion syndrome who are more likely to develop schizophrenia.
Patients in South Florida with metastatic melanoma will soon have access to tumor-infiltrating lymphocyte therapy, or TIL. The therapy will be available at Sylvester Comprehensive Cancer Center and will be South Florida’s only center offering this treatment.
Today, American Counseling Association (ACA) CEO Shawn Boynes, FASAE, CAE, testified at a congressional hearing about the role counselors can play in providing support for Black men and boys and dismantling stigma around mental health concerns.
Children and teens may experience nonmotor seizures for months or years before being seen in an emergency department for a more obvious seizure that includes convulsions, according to a study published in the May 1, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Sharon Dent, Ph.D., professor of Epigenetics and Molecular Carcinogenesis at The University of Texas MD Anderson Cancer Center, has been elected to the National Academy of Sciences (NAS). Dent is a global leader in the field of chromatin research whose foundational work has helped define the role of chromatin in cancer growth and development.
Researchers say a machine learning tool can identify many patients with rare, undiagnosed diseases years earlier, potentially improving outcomes and reducing cost and morbidity. The findings, led by researchers at UCLA Health, are described in Science Translational Medicine.
Researchers at Wake Forest University School of Medicine have been approved for a $1 million award by the Patient-Centered Outcomes Research Institute (PCORI) for a methodology study.
Connecticut Magazine released its “Top Doctors” issue today, listing some of the state’s best physicians, who provide exceptional care for patients. This year’s list includes 109 Yale Cancer Center (YCC) and Smilow Cancer Hospital (SCH) physicians, a 35% increase in “Top Doctors” for SCH and YCC from last year.
Healthy sight allows us to see all of the world’s wonders, and healthy retinas make healthy sight possible. When retinal disease strikes and a clear view of the world is replaced by a curtain-like shadow, central blurriness, or straight lines that appear wavy, it’s critical to seek out the expert care uniquely provided by a retina specialist.
In recognition of National STOP THE BLEED® Month this May, the American College of Surgeons (ACS) encourages everyone to learn how to save a life with three simple steps using ACS STOP THE BLEED training.
Dr. Schmidt joins Loyola from Northwestern Medicine where he was a practicing clinician and associate professor of Emergency Medicine at Northwestern University’s Feinberg School of Medicine for 20 years.
A University of California, Irvine-led team has found evidence of a potential link between patterns of changes in a key pregnancy hormone – placental corticotropin-releasing hormone – and symptoms of postpartum depression.
Twenty years ago today, the East Harlem Health Outreach Partnership (EHHOP) at Mount Sinai opened its doors, creating a new model of community service and patient care. EHHOP, a free student-run, physician-supervised clinic, serves approximately 300 residents of East Harlem every year.
New stem cell therapy in animal model could eventually lead to viable treatment option Researchers at the University of Maryland School of Medicine (UMSOM) have identified an innovation in stem cell therapy to regenerate neural cells in the brain after cardiac arrest in an animal model.
Leapfrog assigns an “A,” “B,” “C,” “D” or “F” grade to general hospitals across the country based on over 30 measures of errors, accidents, injuries and infections as well as the systems hospitals have in place to prevent them.
Scientists have designed a new artificial intelligence model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease.
Get a sneak-peak at what’s coming up at the ATS 2024 later this month with today’s online release of the “American Thoracic Society International Conference Abstracts.”
Researchers have identified a causal genetic variant strongly associated with childhood obesity. The study provides new insight into the importance of the hypothalamus of the brain and its role in common childhood obesity and the target gene may serve as a druggable target for future therapeutic interventions.
A research team from Tufts University School of Medicine and Massachusetts General Hospital is now reporting evidence that hillocks and their stem cells are physiologically distinct from other cells within the lung and consist of a stratified outer layer of scale-like squamous cells that protect an underlying layer of rapidly expanding basal stem cells that are capable of restoring airway tissue after injury.
Event at National Press Club features nutrition, food safety scientists and leaders addressing major issues with a research and regulatory lens.
As a successful outcome of the collaboration announced in 2023 between Mayo Clinic Laboratories, a leading global reference laboratory, and Progentec Diagnostics, a digital health and biomarker technology-based company focused on autoimmune conditions, Progentec’s proprietary biomarker blood tests for the proactive management of systemic lupus erythematosus are available.
The Leapfrog Group has granted University of Chicago Medical Center (UCMC) its 25th consecutive “A” Hospital Safety Grade, making it one of only 15 hospitals nationwide and the only one in Chicago with the “straight A” distinction.
Results of a new clinical trial published in Nature Medicine show that a novel, personalized neoantigen vaccine therapy demonstrated promising anti-tumor efficacy in patients with liver cancer who failed their original front-line treatment. The foundational biomedical research leading to this important study and important outcome originated from research in the Vaccine & Immunotherapy Center at The Wistar Institute.
Long non-coding RNAs (lncRNAs) are ubiquitous transcripts with crucial regulatory roles in various biological processes, including chromatin remodeling, post-transcriptional regulation, and epigenetic modifications.
International collaboration to improve cancer outcomes in Sub-Saharan Africa is working to update consensus harmonized guidelines on several key subjects in oncology, including how best to treat people with both cancer and HIV.
The University of Texas MD Anderson Cancer Center and the Pan American Health Organization (PAHO) today announced the signing of an agreement to strengthen cancer prevention and control initiatives across the Americas. The event took place in Washington, D.C., with leaders from both organizations.
A. Sonia Buist, MD, a past president of the American Thoracic Society and an advocate for global public health policy and respiratory health, has donated $400,000 to the Society, making her the ATS’s highest lifetime donor in its history. Her gift will support the ATS/MECOR Women’s Leadership Program, a new visionary program to enhance leadership capabilities in African women.
The American Cancer Society today released a first-of-its-kind Cancer Facts & Figures for Asian American, Native Hawaiian, & Other Pacific Islander People, 2024-2026. This report shows that despite limited disaggregated data, there is wide variation in the cancer burden among ethnic groups that make up this fast-growing population.
UC Davis study of data from 8500+ ICU patients finds more out-of-bed mobility interventions for critically ill patients were associated with shorter mechanical ventilation duration and hospital stays, suggesting a dose-response relationship between daily mobility and patient outcomes.
A simple blood test could allow doctors to determine whether a person may be at higher risk for stroke or cognitive decline during their lifetime, according to a new UCLA Health study.
Announcement of contents of the May 2024 issue of Neurosurgical Focus
Keck Hospital of USC earned an “A” Hospital Safety Grade from The Leapfrog Group, an independent national watchdog organization.
Artificial intelligence experts at Cedars-Sinai and the Smidt Heart Institute created a dataset with more than 1 million echocardiograms, or cardiac ultrasound videos, and their corresponding clinical interpretations. Using this database, they created EchoCLIP, a powerful machine learning algorithm that can “interpret” echocardiogram images and assess key findings.
A roundup of the latest medical discoveries and faculty news at Cedars-Sinai for April 2024.
Rates of HIV transmission increased when the U.S./Mexico border was closed for COVID-19, according to a new study from University of California San Diego and Irvine.
A Doença de Pick, uma doença neurodegenerativa de origem genética desconhecida, é um tipo raro de demência frontotemporal que afeta pessoas com menos de 65 anos. A condição causa mudanças na personalidade, no comportamento e, às vezes, compromete a linguagem. Em pacientes com a doença, as proteínas Taus se acumulam e formam aglomerados anormais chamados de corpos de Pick, que restringem os nutrientes ao cérebro e causam neurodegeneração.
A team led by a Houston Methodist physician established a hypothesis that the microenvironments of tumors in the pancreatic head versus the body and tail, particularly the immunotherapy receptors found on each section of the pancreas, differ. This could impact the way cancer of the pancreas is treated.
The American Association of Neurological Surgeons (AANS) is thrilled to announce the impressive lineup of esteemed speakers set to headline the highly anticipated 2024 AANS Annual Scientific Meeting, taking place from May 3-5 in the vibrant city of Chicago.
Media representatives are invited to attend and cover this prestigious gathering, which will feature a comprehensive program of presentations, lectures, panel discussions and hands-on workshops covering the latest advancements, research, techniques and breakthroughs in neurosurgery — including artificial intelligence and how it is transforming neurosurgery.
La enfermedad de Pick, una enfermedad neurodegenerativa de origen genético desconocido, es un tipo raro de demencia frontotemporal que afecta a personas menores de 65 años. La condición causa cambios en la personalidad, en el comportamiento y, a veces, compromete el lenguaje. En pacientes con la enfermedad, las proteínas Taus se acumulan y forman grupos anormales llamados cuerpos Pick, que restringen los nutrientes al cerebro y causan neurodegeneración.
Hackensack Meridian Mountainside Medical Center is proud to announce the successful completion of its first bronchoscopy procedure using the Ion Endoluminal System, a cutting-edge robotic-assisted technology designed for minimally invasive lung biopsies.
مرض بيك، المرض التنكسي العصبي ذو الأصل الوراثي غير المعروف، هو خرف جبهي صدغي يؤثر على الأشخاص تحت سن 65 عامًا. تتسبب الحالة في حدوث تغييرات في الشخصية والسلوك واضطراب في اللغة أحيانًا. بالنسبة للمرضى المصابون بهذا المرض، تتراكم بروتينات تاو وتشكل كتلًا غير طبيعية تسمى أجسام بيك؛ التي تعمل على تقييد وصول العناصر المغذية إلى الدماغ وتسبب تنكسًا عصبيًا. والطريقة الوحيدة لتشخيص المرض هي فحص أنسجة الدماغ تحت المجهر بعد وفاة الشخص.
Mitchell Schnall, MD, PhD, has been appointed to a newly created role as Senior Vice President for Data and Technology Solutions for the University of Pennsylvania Health System (UPHS), following two terms as Chair of Radiology in Penn’s Perelman School of Medicine. In his new role, he will lead teams and projects that will pave a path for Penn Medicine to lead the health care industry into a new, technology- and data-driven era.
Preoperative Botox injections are a useful test for predicting how well patients with chronic migraine will respond to nerve decompression surgery, reports a study in the May issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS). The journal is published in the Lippincott portfolio by Wolters Kluwer.
In an effort to improve delivery of costly medical treatments, a team of researchers in electrical engineering at the University of Wisconsin–Madison has developed a stimulating method that could make the human body more receptive to certain gene therapies.
Ann & Robert H. Lurie Children’s Hospital of Chicago is pleased to announce the first pediatric use of the novel fluorescent agent CYTALUX during surgery to remove lung metastases. The drug allows surgeons to better visualize cancer in the lung, as well as potentially detect additional cancerous nodules missed by preoperative imaging.